Concepedia

Junzo Hamanishi

JH

Statistics

Publications

79

Citations

8.9K

H-Index

36

Active since

2002

Affiliations

Kyoto University(Current)

Kindai University

Kyoto Medical Center

Duke Medical Center

Kyoto University Hospital

Junzo Hamanishi is an author at Kyoto University specializing in oncology, medicine, and ovarian cancer.

ORCID

Publications per year

2002–2025

79

Publications

79

Programmed cell death 1 ligand 1 and tumor-infiltrating CD8 <sup>+</sup> T lymphocytes are prognostic factors of human ovarian cancer

Junzo Hamanishi, Masaki Mandai, Masashi Iwasaki et al. · Proceedings of the National Academy of Sciences · 2007 · 1.4K citations · Full text

, , +17

Safety and Antitumor Activity of Anti–PD-1 Antibody, Nivolumab, in Patients With Platinum-Resistant Ovarian Cancer

Junzo Hamanishi, Masaki Mandai, Takafumi Ikeda et al. · Journal of Clinical Oncology · 2015 · 1.2K citations

, , +17

IFN-γ from lymphocytes induces PD-L1 expression and promotes progression of ovarian cancer

Kaoru Abiko, Noriomi Matsumura, Junzo Hamanishi et al. · British Journal of Cancer · 2015 · 709 citations · Full text

, , +17

Host expression of PD-L1 determines efficacy of PD-L1 pathway blockade–mediated tumor regression

Heng Lin, Shuang Wei, Elaine M. Hurt et al. · Journal of Clinical Investigation · 2018 · 602 citations · Full text

, , +17

Chemotherapy Induces Programmed Cell Death-Ligand 1 Overexpression via the Nuclear Factor-κB to Foster an Immunosuppressive Tumor Microenvironment in Ovarian Cancer

Peng Jin, Junzo Hamanishi, Noriomi Matsumura et al. · Cancer Research · 2015 · 522 citations

, , +17

1–5 of 79